Boston-based startup Rhino Health is making waves in healthcare with its AI platform, which simplifies access to diverse datasets for developing and improving medical algorithms. In July 2024, Rhino Health raised $16 million in Series A funding, reflecting growing investor interest in AI applications for healthcare.
Rhino Health’s platform allows medical researchers and developers to tap into multiple data sources securely and scalably. By enabling access to disparate datasets, Rhino Health is helping AI developers create more accurate and effective healthcare solutions. This capability is particularly important as healthcare moves toward more personalised, data-driven care.
“We’re focused on making clinical AI development faster and more effective,” said Ittai Dayan, co-founder and CEO of Rhino Health. “Our platform empowers developers by giving them access to the right data while ensuring patient privacy and compliance with regulations”(Startup Savant).
Investors, such as LionBird and Arkin Digital Health, have shown strong support for the company’s vision. “Rhino Health is uniquely positioned to accelerate AI in healthcare, thanks to its powerful platform that integrates data from multiple sources while maintaining privacy,” said an investor involved in the Series A round(Startup Savant).
